154 related articles for article (PubMed ID: 35004757)
1. Tocilizumab in the Treatment of Chronic Antibody-Mediated Rejection Post Kidney Transplantation: Clinical and Histological Monitoring.
Noble J; Giovannini D; Laamech R; Imerzoukene F; Janbon B; Marchesi L; Malvezzi P; Jouve T; Rostaing L
Front Med (Lausanne); 2021; 8():790547. PubMed ID: 35004757
[No Abstract] [Full Text] [Related]
2. Lack of Histological and Molecular Signature Response to Tocilizumab in Kidney Transplants with Chronic Active Antibody Mediated Rejection: A Case Series.
Kumar D; Yakubu I; Safavi F; Levy M; Moinuddin I; Kimball P; Kamal L; King A; Massey D; Halloran P; Gupta G
Kidney360; 2020 Jul; 1(7):663-670. PubMed ID: 35372943
[TBL] [Abstract][Full Text] [Related]
3. The clinical and genomic significance of donor-specific antibody-positive/C4d-negative and donor-specific antibody-negative/C4d-negative transplant glomerulopathy.
Hayde N; Bao Y; Pullman J; Ye B; Calder RB; Chung M; Schwartz D; Lubetzky M; Ajaimy M; de Boccardo G; Akalin E
Clin J Am Soc Nephrol; 2013 Dec; 8(12):2141-8. PubMed ID: 24030736
[TBL] [Abstract][Full Text] [Related]
4. T-bet-positive mononuclear cell infiltration is associated with transplant glomerulopathy and interstitial fibrosis and tubular atrophy in renal allograft recipients.
Yadav B; Prasad N; Agrawal V; Jain M; Agarwal V; Jaiswal A; Bhadauria D; Sharma RK; Gupta A
Exp Clin Transplant; 2015 Apr; 13(2):145-51. PubMed ID: 25871366
[TBL] [Abstract][Full Text] [Related]
5. Early effects of first-line treatment with anti-interleukin-6 receptor antibody tocilizumab for chronic active antibody-mediated rejection in kidney transplantation.
Lavacca A; Presta R; Gai C; Mella A; Gallo E; Camussi G; Abbasciano I; Barreca A; Caorsi C; Fop F; Messina M; Rossetti M; Biancone L
Clin Transplant; 2020 Aug; 34(8):e13908. PubMed ID: 32415711
[TBL] [Abstract][Full Text] [Related]
6. Tocilizumab for treatment of chronic active antibody-mediated rejection in kidney transplant recipients.
Boonpheng B; De Castro ICC; Ng YH; Blosser C; Bakthavatsalam R; Gimferrer I; Smith K; Leca N
Clin Transplant; 2023 May; 37(5):e14936. PubMed ID: 36787372
[TBL] [Abstract][Full Text] [Related]
7. Tocilizumab in the treatment of active chronic humoral rejection resistant to standard therapy.
Chamoun B; Sánchez-Sancho P; Torres IB; Gabaldon A; Perelló M; Sellarés J; Moreso F; Serón D
Nefrologia (Engl Ed); 2022; 42(5):578-584. PubMed ID: 36717307
[TBL] [Abstract][Full Text] [Related]
8. Impact of Tocilizumab (Anti-IL-6R) Treatment on Immunoglobulins and Anti-HLA Antibodies in Kidney Transplant Patients With Chronic Antibody-mediated Rejection.
Shin BH; Everly MJ; Zhang H; Choi J; Vo A; Zhang X; Huang E; Jordan SC; Toyoda M
Transplantation; 2020 Apr; 104(4):856-863. PubMed ID: 31385933
[TBL] [Abstract][Full Text] [Related]
9. Refinement of the criteria for ultrastructural peritubular capillary basement membrane multilayering in the diagnosis of chronic active/acute antibody-mediated rejection.
Go H; Shin S; Kim YH; Han DJ; Cho YM
Transpl Int; 2017 Apr; 30(4):398-409. PubMed ID: 28109026
[TBL] [Abstract][Full Text] [Related]
10. Clinical and pathological analyses of transplant glomerulopathy cases.
Shimizu T; Ishida H; Toki D; Nozaki T; Omoto K; Tanabe K; Honda K; Koike J
Nephrology (Carlton); 2014 Jun; 19 Suppl 3():21-6. PubMed ID: 24842817
[TBL] [Abstract][Full Text] [Related]
11. Subclinical peritubular capillaritis at 3 months is associated with chronic rejection at 1 year.
Lerut E; Naesens M; Kuypers DR; Vanrenterghem Y; Van Damme B
Transplantation; 2007 Jun; 83(11):1416-22. PubMed ID: 17565313
[TBL] [Abstract][Full Text] [Related]
12. Sonography of the renal allograft: Correlation between doppler sonographic resistance index (RI) and histopathology.
Preuss S; Rother C; Renders L; Wagenpfeil S; Büttner-Herold M; Slotta-Huspenina J; Holtzmann C; Kuechle C; Heemann U; Stock KF
Clin Hemorheol Microcirc; 2018; 70(4):413-422. PubMed ID: 30562894
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and Safety of Bone Marrow-Derived Mesenchymal Stem Cells for Chronic Antibody-Mediated Rejection After Kidney Transplantation- A Single-Arm, Two-Dosing-Regimen, Phase I/II Study.
Wei Y; Chen X; Zhang H; Su Q; Peng Y; Fu Q; Li J; Gao Y; Li X; Yang S; Ye Q; Huang H; Deng R; Li G; Xu B; Wu C; Wang J; Zhang X; Su X; Liu L; Xiang AP; Wang C
Front Immunol; 2021; 12():662441. PubMed ID: 34248942
[TBL] [Abstract][Full Text] [Related]
14. Treatment with plasmapheresis, immunoglobulins and rituximab for chronic-active antibody-mediated rejection in kidney transplantation: Clinical, immunological and pathological results.
Mella A; Gallo E; Messina M; Caorsi C; Amoroso A; Gontero P; Verri A; Maletta F; Barreca A; Fop F; Biancone L
World J Transplant; 2018 Sep; 8(5):178-187. PubMed ID: 30211026
[TBL] [Abstract][Full Text] [Related]
15. Profiling of mRNA of interstitial fibrosis and tubular atrophy with subclinical inflammation in recipients after kidney transplantation.
Fu Q; Liao M; Feng C; Tang J; Liao R; Wei L; Yang H; Markmann JF; Chen K; Deng S
Aging (Albany NY); 2019 Jul; 11(14):5215-5231. PubMed ID: 31343413
[TBL] [Abstract][Full Text] [Related]
16. Capillary C4d and Kidney Allograft Outcome in Relation to Morphologic Lesions Suggestive of Antibody-Mediated Rejection.
Kikić Ž; Kainz A; Kozakowski N; Oberbauer R; Regele H; Bond G; Böhmig GA
Clin J Am Soc Nephrol; 2015 Aug; 10(8):1435-43. PubMed ID: 26071493
[TBL] [Abstract][Full Text] [Related]
17. A Banff Component Scoring-based Histologic Assessment of Bortezomib-based Antibody-mediated Rejection Therapy.
Sadaka B; Ejaz NS; Shields AR; Cardi MA; Wadih G; Witte D; Abu Jawdeh BG; Alloway RR; Woodle ES
Transplantation; 2015 Aug; 99(8):1691-9. PubMed ID: 25803498
[TBL] [Abstract][Full Text] [Related]
18. Long-term graft survival in patients with chronic antibody-mediated rejection with persistent peritubular capillaritis treated with intravenous immunoglobulin and rituximab.
Mulley WR; Huang LL; Ramessur Chandran S; Longano A; Amos LAR; Polkinghorne KR; Nikolic-Paterson DJ; Kanellis J
Clin Transplant; 2017 Sep; 31(9):. PubMed ID: 28640458
[TBL] [Abstract][Full Text] [Related]
19. Case Report: Splenic Irradiation for the Treatment of Chronic Active Antibody-Mediated Rejection in Kidney Allograft Recipients With
Zhu L; Guo Z; Sa R; Guo H; Li J; Chen G
Front Immunol; 2021; 12():661614. PubMed ID: 33936098
[TBL] [Abstract][Full Text] [Related]
20. A type I interferon signature characterizes chronic antibody-mediated rejection in kidney transplantation.
Rascio F; Pontrelli P; Accetturo M; Oranger A; Gigante M; Castellano G; Gigante M; Zito A; Zaza G; Lupo A; Ranieri E; Stallone G; Gesualdo L; Grandaliano G
J Pathol; 2015 Sep; 237(1):72-84. PubMed ID: 25925804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
